REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Aspal Medical S.A. Aspalmed (Ecuador)

Main Activities: Pharmacies and Drug Stores
Full name: Aspal Medical S.A. Aspalmed Profile Updated: April 15, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Aspal Medical S.A. Aspalmed is an enterprise located in Ecuador, with the main office in Guayaquil. The enterprise operates in the Pharmacies and Drug Stores industry. The company was established on December 03, 2013. The total number of employees is currently 15 (2023). The latest financial highlights indicate a net sales revenue increase of 37.96% in 2023. Over the same period, its total assets grew by 8.93%. In 2023, Aspal Medical S.A. Aspalmed’s net profit margin increased by 0.13%.

Headquarters
Mirtos 1016
Guayaquil; Guayas;

Contact Details: Purchase the Aspal Medical S.A. Aspalmed report to view the information.

Basic Information
Total Employees:
Purchase the Aspal Medical S.A. Aspalmed report to view the information.
Outstanding Shares:
Purchase the Aspal Medical S.A. Aspalmed report to view the information.
Registered Capital:
Purchase the Aspal Medical S.A. Aspalmed report to view the information.
Incorporation Date:
December 03, 2013
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
75.92%
Purchase this report to view the information.
12.3%
Purchase this report to view the information.
11.78%
Company Performance
Financial values in the chart are available after Aspal Medical S.A. Aspalmed report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
37.96%▲
Total operating revenue
34.91%▲
Operating profit (EBIT)
N/A
Net Profit (Loss) for the Period
51.87%▲
Total assets
8.93%▲
Total equity
9.2%▲
Operating Profit Margin (ROS)
N/A
Net Profit Margin
0.13%▲
Return on Equity (ROE)
2.37%▲
Debt to Equity Ratio
31.49%▲
Quick Ratio
-0.54%▼
Cash Ratio
-0.01%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo